Anthony M. Manning, Chief Scientific Officer at MOMENTA PHARMACEUTICALS INC (MNTA), sold 112 shares at $32.23 ($4K) on 2020-02-11, disclosed to the SEC on 2020-02-12.
Scheduled sale ($4k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MNTA | SELL | 2020-08-13 | $12K | — | Filing → |
| MNTA | SELL | 2020-08-11 | $11K | — | Filing → |
| MNTA | SELL | 2020-07-23 | $128K | — | Filing → |